Month: July 2019

President Donald Trump Jabin Botsford | The Washington Post | Getty Images Pharmaceutical companies may be in the direct path of President Donald Trump‘s next big policy push to lower drug prices after the administration abandoned a proposal that would have eliminated rebates from government drug plans. Earlier Thursday, the White House said the Trump
0 Comments
Introducing the Forbes OZ 20 Forbes Ambitious, bold, bipartisan—and controversial, Opportunity Zones can be a powerful policy tool to spark transformative investment in America’s left behind communities. Passed as part of the 2017 U.S. tax overhaul, Opportunity Zones offer massive potential tax breaks for investors and organizations who plow unrealized gains into impoverished areas. Based
0 Comments